Advertisement

Topics

Search Results for "Tailand Swine Influenza Vaccine Market"

04:17 EDT 2nd May 2016 | BioPortfolio

Matching Channels

Matching News

Influenza Virus Surveillance in US Swine Production Systems

This study investigates the prevalence of influenza A viruses in coordinated swine production systems in the United States. Emerging Infectious Diseases

FDA Approves Fluad (influenza vaccine, adjuvanted) for Prevention of Seasonal Influenza

November 24, 2015 -- The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza v...

Human Swine Flu (H1N1) and Novel Influenza Pandemics

Vaccine experts and public health officials met at the Academy to discuss the latest about the outbreak. A complete eBriefing is now available, including video interviews with the CDC's Michael Shaw a...

H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure

GSK announced today that the U.S. Food and Drug Administration (FDA) has approved its pandemic Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (also referred to as Q-Pan H5N1 influenza vaccin...

FDA approves first seasonal influenza vaccine containing an adjuvant

The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two sub...

Influenza Vaccine Approved in Mexico

Protein Sciences Corporation, manufacturer of Flublok, is pleased to announce that Laboratorios Liomont, S.A. de C.V., a leading Mexican pharmaceutical company and licensee of Flublok for the Mexic...

ACIP: Flu vaccine 59% effective to date

The CDC’s Advisory Committee for Immunization Practices continued to recommend that all people aged 6 months and older be vaccinated annually against influenza during its recent meeting and also ame...

FDA Approves GlaxoSmithKline’s four-strain seasonal influenza vaccine for use in the US

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX® QUADRIVALENT (Influenza Virus Vaccine) for the immunisation of children (three years and...

Matching PubMed Articles

Effect of AcHERV-GmCSF as an Influenza Virus Vaccine Adjuvant.

The first identification of swine-originated influenza A/CA/04/2009 (pH1N1) as the cause of an outbreak of human influenza accelerated efforts to develop vaccines to prevent and control influenza viru...

Influenza B vaccine lineage selection-An optimized trivalent vaccine.

Epidemics of seasonal influenza viruses cause considerable morbidity and mortality each year. Various types and subtypes of influenza circulate in humans and evolve continuously such that individuals ...

Ineffectiveness of the 2014-2015 H3N2 influenza vaccine.

The seasonal influenza vaccine is currently the most effective preventive modality against influenza infection. Nasopharyngeal samples of vaccinated and non-vaccinated patients presenting with Influen...

Optimal Use of Vaccines for Control of Influenza A Virus in Swine.

Influenza A virus in swine (IAV-S) is one of the most important infectious disease agents of swine in North America. In addition to the economic burden of IAV-S to the swine industry, the zoonotic pot...

Predictors of influenza vaccine uptake during the 2009/10 influenza A H1N1v ('swine flu') pandemic: Results from five national surveys in the United Kingdom.

To investigate reasons underlying the low uptake of the influenza A H1N1v vaccination in the UK during the 2009/10 pandemic.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement